Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats

Background: Portal hypertension is characterized by exaggerated activation of the renin-angiotensin-aldosterone axis. Natriuretic peptide system plays a counter-regulatory role, which is modulated by neprilysin. LCZ696 (sacubitril/valsartan) is a dual angiotensin receptor and neprilysin inhibitor. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shao-Jung, Huang, Hui-Chun, Chuang, Chiao-Lin, Chang, Ching-Chih, Hou, Ming-Chih, Lee, Fa-Yauh, Lee, Shou-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238216/
https://www.ncbi.nlm.nih.gov/pubmed/32252377
http://dx.doi.org/10.3390/pharmaceutics12040320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238216/
https://www.ncbi.nlm.nih.gov/pubmed/32252377
http://dx.doi.org/10.3390/pharmaceutics12040320

Ejemplares similares